Reuters logo
in 4 months
BRIEF-Mylan receives CRL for generic Advair Diskus ANDA
March 29, 2017 / 5:24 PM / in 4 months

BRIEF-Mylan receives CRL for generic Advair Diskus ANDA

1 Min Read

March 29 (Reuters) - Mylan NV:

* Mylan comments on generic Advair Diskus abbreviated new drug application

* In conjunction with Mylan's GDUFA goal date, company received a complete response letter from FDA regarding its ANDA for generic Advair Diskus

* Is in process of reviewing the response and will provide an update on its application as soon as practicable once it has completed its review Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below